Company intelligence / Profile preview

Cohero Health

New York, New York, United Statesaptar.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cohero Health developed FDA-cleared connected spirometers and smart inhaler sensors to monitor lung function and medication adherence. Their digital therapeutics demonstrated improved patient engagement and outcomes in respiratory care. The company was acquired by Aptar Pharma in November 2020; its technologies are now part of the Aptar Digital Health offering

Therapeutic areas: Pulmonology
Modalities: DeviceDigital therapeutic (platform/software)Wearable health sensor technology
Industry: Physiological Monitoring

Partnerships

Samsung, Omron (investors/partners)integration with healthcare providers for clinical studies

Beyond the preview

Go deeper on Cohero Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cohero Health.

Explore the full profile